Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Eternity Bioscience patents new Raf kinase inhibitors

May 27, 2022

Researchers highlight use of NUAK2 inhibitor HTH-02-006 for treating prostate cancer

May 27, 2022

New EGFR inhibitors identified at Lengo Therapeutics

May 26, 2022

Rhizen Pharmaceuticals divulges new PARP inhibitors

May 26, 2022

Newave Pharmaceutical discloses new BTK inhibitors

May 26, 2022

Integral BioSciences patents ENPP1 inhibitors

May 26, 2022

In vitro study supports use of VAL-001 for relapsing DLBCL

May 25, 2022

Lysine reactive salicylaldehyde probe exhibits kinase selectivity with sustained occupancy

May 25, 2022

In4Derm Limited presents new BRD4 BD2 inhibitors

May 25, 2022

Chinese researchers identify HSP90A inhibitors

May 25, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...